Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Intestinal Neoplasms × Simvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 5 Multiple Myeloma 5 Breast Neoplasms 5 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Carcinoma In Situ 2 Wilms Tumor 1 Venous Thromboembolism 1 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Thrombosis 1 Smoldering Multiple Myeloma 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Rectal Neoplasms 1 Perioperative Inflammatory Response 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurotoxicity Syndromes 1 Neuroblastoma 1

Interventions

Irinotecan 3 Fluorouracil 3 Bevacizumab 3 Oxaliplatin 2 Leucovorin 2 Capecitabine 2 Bisacodyl 2 Aspirin 2 lutetium Lu 177 dotatate 1 guadecitabine 1 copper dotatate CU-64 1 camrelizumab 1 apatinib 1 XELOX 1 Ursodeoxycholic Acid 1 Trastuzumab 1 Simvastatin 1 Radiotherapy 1 Polyethylene Glycols 1 Oviposition 1 Lutetium-177 1 Lutetium 1 Ileostomy 1 Drainage 1 Cyclophosphamide 1 Colonoscopy 1 Chemoradiotherapy 1 Celecoxib 1 Cathartics 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00994903 2013-12-02

StatCol

University of Auckland, New Zealand

Phase 3 Completed

Intestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡